Concepedia

James A. Ruggles

JA

15

Publications

1.8K

Citations

14

H-Index

1985

Active since

Affiliations

University of Colorado Boulder(Current)

Diabetes & Glandular Disease Clinic

AstraZeneca (United States)

Amplyx Pharmaceuticals (United States)

James A. Ruggles is an author at University of Colorado Boulder specializing in molecular biology, structural biology, and natural sciences.

Top concepts

Publications per year

1985–2019

15

Publications

15

Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus

Orville Kolterman, Dennis Dong Hwan Kim, Larry Z. Shen et al. · American Journal of Health-System Pharmacy · 2005 · 434 citations

A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes

Fred W. Whitehouse, Davida Kruger, Mark Fineman et al. · Diabetes Care · 2002 · 258 citations · Full text

Crystal Structure of the Oxytricha nova Telomere End Binding Protein Complexed with Single Strand DNA

Martin P. Horvath, Viloya L Schweiker, Joanne M. Bevilacqua et al. · Cell · 1998 · 252 citations · Full text

, , +5

Effect of Pramlintide on Weight in Overweight and Obese Insulin‐Treated Type 2 Diabetes Patients

Priscilla Hollander, David Maggs, James A. Ruggles et al. · Obesity Research · 2004 · 192 citations · Full text

Adjunctive Therapy with the Amylin Analogue Pramlintide Leads to a Combined Improvement in Glycemic and Weight Control in Insulin-Treated Subjects with Type 2 Diabetes

Robert E. Ratner, Laura L. Want, Mark Fineman et al. · Diabetes Technology & Therapeutics · 2002 · 154 citations

Rows per page

1–5 of 15